Emilio Bajetta

26.3k citations
325 papers · 16.6k indexed · 6 hit papers · h-index 55

Emilio Bajetta

317 papers receiving 15.9k citations

Hit Papers

Phase III Trial of Bevaciz...632197620261992200950010001.5k

Peers

Emilio Bajetta
Comparison fields: 5 of 143
  • Oncology 10.4k
  • Cancer Research 3.7k
  • Pulmonary and Respiratory Medicine 5.8k
  • Hepatology 948
  • Neurology 1.4k
Replace Allan T. van Oosterom with:
Allan T. van Oosterom Belgium
Patrick Schöffski Belgium
Joel Picus United States
Robert S. Benjamin United States
Afshin Dowlati United States
Filippo de Braud Italy
Jordan Berlin United States
Hedy L. Kindler United States
Yoshitaka Fujii Japan
Kim Margolin United States
Emilio Bajetta relative to Allan T. van Oosterom Belgium Allan T. van Oosterom's profile →
Citations per field
00.5×1.5×
Allan T. van Oosterom · 1×
Citations per year

Countries citing papers authored by Emilio Bajetta

Since Specialization
Citations

This map shows the geographic impact of Emilio Bajetta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emilio Bajetta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emilio Bajetta more than expected).

Fields of papers citing papers by Emilio Bajetta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emilio Bajetta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emilio Bajetta. The network helps show where Emilio Bajetta may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Emilio Bajetta, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Emilio Bajetta Line = papers co-authored together Emilio Bajetta links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1
Efficacy of Octreotide Long-Acting Repeatable (OCT) From the Phase III RADIANT-2 Study in Patients With Advanced Neuroendocrine Tumors (NET) : A Post-Hoc Analysis of the Placebo (PBO) Arm With Updated Survival Data
20151
2 20152
3 201416
4 201226
5 201044
6 200813
7 200810
8 2007264
9
Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trialbreakdown →
20071722
10 20071
11 2007128
12 200611
13 20044
14 2004115
15 200315
16
Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancerbreakdown →
1998786
17 1998121
18 199537
19 1993107
20
Controlled studies with bleomycin in solid tumors and lymphomas.
19761

About Emilio Bajetta

Emilio Bajetta is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 325 papers that have together received 16.6k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (59 papers), Neuroendocrine Tumor Research Advances (55 papers), Cancer Treatment and Pharmacology (54 papers), Lung Cancer Research Studies (54 papers), Estrogen and related hormone effects (41 papers), Neuroblastoma Research and Treatments (40 papers), Lung Cancer Treatments and Mutations (36 papers) and Gastric Cancer Management and Outcomes (34 papers). The work is most often cited by research in Oncology (10.4k citations), Cancer Research (3.7k citations) and Pulmonary and Respiratory Medicine (5.8k citations). Emilio Bajetta has collaborated with scholars based in Italy, United States and Switzerland. Frequent co-authors include Roberto Buzzoni, Sergio Bracarda, Maria Di Bartolomeo, Nicoletta Zilembo, Bernard Escudier, Alain Ravaud, Bohuslav Melichar, Gianni Bonadonna, Antonia Martinetti and Luigi Celio. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer, Cancer and Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026